EG.5.1 was first raised as a signal in monitoring on July 3, 2023, as part of horizon scanning due to increasing reports internationally, particularly in Asia
Studying asymptomatic infection may improve our understanding of the features of the immune system that promote rapid clearance of the virus
The device can be used in hospitals and health care facilities, schools and public places to help detect SARS-CoV-2 and potentially monitor for other respiratory virus...
The first case of coronavirus infection in the country was recorded on January 30, 2020 from Kerala and the first death was reported on March 10,...
GEMCOVAC-OM is India's first mRNA vaccine developed using the indigenous platform technology by Gennova, with funding support from Department of Biotechnology (DBT) and Biotechnology Industry Research...
GEMCOVAC-OM is an Omicron-specific mRNA-based booster vaccine developed using the indigenous platform technology by Gennova in collaboration with DBT
The study, co-led by Murdoch Children's Research Institute and the Peter Doherty Institute for Infection and Immunity (Doherty Institute), discovered that SARS-CoV-2 responses varied significantly depending...
A recent study from the Allen Institute and Fred Hutchinson Cancer Centre discovered a group of chemicals linked to inflammation that were only detectable in a...
Over 90 per cent of long Covid patients using the app were of working age (18-65) and 51 per cent said they had been unable to...
The research, published in BMJ Open and funded by the National Institute for Health and Care Research (NIHR), examines the impact of long Covid on the...
Seventeen per cent of participants did not return to normal health and 18 per cent reported covid-19 related symptoms 24 months after initial infection, the study...
The team from the University of Colorado (CU) Boulder in the US hopes that the frequency comb breathalyser—essentially using laser light to distinguish one molecule from...